| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |